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factors, abortion was not a statistically
signiﬁcant predictor of subsequent anx-
iety, mood, impulse-control, and eating
disorders or suicidal ideation.”1
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Effects of Age, Parity, and
Device Type on Complications
and Discontinuation of
Intrauterine Devices
To the Editor:
The retrospective chart review by Aoun
et al1 analyzed intrauterine device
(IUD)–related outcomes by age, parity,
and IUD type. One of the authors’ main
conclusions was that teenagers and
young women may beneﬁt from
additional counseling because they
are more likely to request removal
before product expiration. The authors
identify in the Discussion that the pri-
mary causes of early removal are pain
and bleeding. However, the data and
available literature do not support this
conclusion. First, although univariate
analysis does show a signiﬁcant differ-
ence in discontinuation rates for pain
and abnormal bleeding, only pain ap-
pears to be related to age. The percent-
age of young (aged 13–19 years)
females that discontinued because of
abnormal bleeding was lower than
women aged 25–35 years. More
importantly, although the study meth-
ods include a description of a multivar-
iable analysis, none is presented in the
results. In this type of study, only with
multivariable analysis can this univari-
ate ﬁnding be validated.
Second, as the authors brieﬂy
review in the Discussion, teenagers
are more likely to discontinue all meth-
ods of contraception. However, our
goal as providers should not be to
achieve the same continuation rates
among women of all ages, races, and
cultures. All women are different, and
teenagers are different than more
mature women in many ways, not just
in contraceptive choices and continua-
tion rates. The CHOICE study demon-
strates that teenagers who receive
extensive counseling, choose IUDs,
and have signiﬁcant provider support
have a lower rate of continuation as
compared with women aged 20 years
and older.2 However, teenagers in the
CHOICE study who selected an IUD
were also much more likely to continue
their method compared with those who
chose short-acting methods of contra-
ception. One of the realities of highly
effective, long-acting methods of con-
traception is that they are not perfect
for everyone. The authors in this study
have done a great job of evaluating the
available data from a retrospective
review of patient charts to get an idea
of the rates of and reasons for discon-
tinuation. However, the data as well as
the available literature do not support
the recommendation that providing
extra counseling to teenagers will lower
discontinuation rates. All women,
regardless of age, deserve the best
counseling.
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Editor’s Note: Aoun et al declined to respond to
this letter.
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and Discontinuation of
Intrauterine Devices
To the Editor:
We read the study by Aoun et al,1 and we
would like to express some concerns and
make some comments. As evidenced in
many recent articles that have appeared
in journals worldwide, many young
women experience problems during intra-
uterine device (IUD) use, particularly nul-
liparous women. This is not surprising—
researchers have demonstrated the great
disparity between uterine cavities, particu-
larly the transverse dimensions of the cav-
ity, which were found to be on average
only about 2.5–2.7 cm in the fundal area
in nulliparous women and only margin-
ally wider in women who had given
birth.2,3 Paragard and Mirena are 3.2-cm
wide, and, therefore, will not ﬁt in many
uterine cavities. Several authors conclude
that side effects (eg, bleeding, pain) are the
consequence of disproportion between the
IUD and the endometrial cavity, which
leads to early discontinuation.4,5 Trans-
verse uterine cavity lengths of between
1.1 and 1.6 cm are not altogether uncom-
mon.6 Although some women seemingly
tolerate this disproportion, others will try
to endure these side effects (if the device is
not expelled due to severe uterine contrac-
tions) and take large doses of painkillers,
hoping that the cramps will subside. How-
ever, if this is not the case, they will
request removal of the IUD and switch
to another, less-effective method of contra-
ception or no method at all. Garbers et al4
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